MK-8237 (SCH900237) Biomarker Study in Participants With Allergic Rhinitis or Rhinoconjunctivitis (MK-8237-009)

NCT01852825 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhinitis
Allergic Rhinoconjunctivitis

Interventions

BIOLOGICAL: MK-8237
OTHER: Placebo
BIOLOGICAL: NAC

Sponsor

Merck Sharp & Dohme LLC

Collaborators

[object Object]